Literature DB >> 16517696

Cutting Edge: CD28 controls dominant regulatory T cell activity during active immunization.

Clay Lyddane1, Beata U Gajewska, Elmer Santos, Philip D King, Glaucia C Furtado, Michel Sadelain.   

Abstract

Ligation of CD28 during Ag recognition plays an important role in the generation of effective T cell responses. However, its peripheral control of regulatory T cell function remains obscure. In this study, we show that naive wild-type or CD28(-/-) CD4(+)CD25(-) T cells exposed to peptide in vivo develop regulatory activity that suppresses the response of adoptively transferred naive T cells to a subsequent immunogenic challenge. We find that although CD28 is engaged during the initial peptide-priming event and is essential to sustain T cell survival, it is not sufficient to prevent the dominance of regulatory T cell function. Immunization with adjuvant abrogates regulatory dominance, reducing overall Foxp3 expression in a CD28-dependent manner. We conclude that CD28 licenses active immunization by regulating Ag-induced immunoregulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517696     DOI: 10.4049/jimmunol.176.6.3306

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.

Authors:  T Zhang; S Fresnay; E Welty; N Sangrampurkar; E Rybak; H Zhou; X-F Cheng; Q Feng; C Avon; A Laaris; M Whitters; A M Nagelin; R M O'Hara; A M Azimzadeh
Journal:  Am J Transplant       Date:  2011-07-12       Impact factor: 8.086

Review 2.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

3.  An obligate cell-intrinsic function for CD28 in Tregs.

Authors:  Ruan Zhang; Alexandria Huynh; Gregory Whitcher; Jihoon Chang; Jonathan S Maltzman; Laurence A Turka
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

4.  CD28 costimulation is essential for human T regulatory expansion and function.

Authors:  Tatiana N Golovina; Tatiana Mikheeva; Megan M Suhoski; Nicole A Aqui; Victoria C Tai; Xiaochuan Shan; Ronghua Liu; R Robert Balcarcel; Nancy Fisher; Bruce L Levine; Richard G Carroll; Noel Warner; Bruce R Blazar; Carl H June; James L Riley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

5.  Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.

Authors:  Cláudia A Zago; Karina R Bortoluci; Luiz R Sardinha; Fernando D Pretel; Sheyla I Castillo-Méndez; Ana Paula Freitas do Rosário; Meire I Hiyane; Sandra M Muxel; Sérgio M Rodriguez-Málaga; Ises A Abrahamsohn; José M Álvarez; Maria Regina D'Império Lima
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

6.  Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches.

Authors:  MyLinh T Duong; Matthew R Collinson-Pautz; Eva Morschl; An Lu; Slawomir P Szymanski; Ming Zhang; Mary E Brandt; Wei-Chun Chang; Kelly L Sharp; Steven M Toler; Kevin M Slawin; Aaron E Foster; David M Spencer; J Henri Bayle
Journal:  Mol Ther Oncolytics       Date:  2018-12-20       Impact factor: 7.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.